Agenda

Day 1
Day 2

07.30-07.55

Participant registration

07.55-08.00

Opening

08.00-08.05

Singing Indonesia national anthem

08.05-08.10

Welcoming speech and opening ceremony

Plenary Session 1

Building up multidisciplinary cancer care: global standards, local determination, and institutional role

08.10-08.35

Multidisciplinary approach in cancer management: global standards

08.35-08.50

Multidisciplinary approach in cancer management: Yogyakarta experience

08.50-08.57

Institutional role: initiation and strengthening of multidisciplinary cancer management

08.57-09.04

Institutional role: advancing education, collaboration, and institutional excellence

09.04-09.19

Discussion

09.19-09.25

Photo session

Plenary Session 2

Lung cancer: Navigating diagnostic complexity and applying therapeutic innovation

09.25-09.45

Lung cancer: Navigating diagnostic complexity and applying therapeutic innovation

09.45-09.55

Discussion

09.55

Coffee Break

Symposium I

Multidisciplinary care models for patients with early to advanced NSCLC

09.55-10.25

Perioperative treatment strategies in NSCLC: A surgeons perspective

10.25-10.55

Targeting immune response across lung cancer propagation: from early to advance disease

10.55-11.15

Case presentation and panel discussion

11.15-11.25

Discussion

Symposium II

Colorectal cancer: Addressing unmet needs with emerging later-line strategies in metastatic disease

11.25-11.45

Surgical management in later line treatment strategies of metastatic colorectal cancer

11.45-12.05

Unmet needs of the existing later-line therapies in metastatic colorectal cancer

12.05-12.25

Case sharing and discussion in metastatic colorectal cancer

12.25-12.45

Discussion

Lunch Symposium

Evolution of HER2 and hormone-receptor positive breast cancer treatment paradigm

12.45-13.05

Targeting HER2-low and HER2-ultralow in chemotherapy naive HR+ HER2 negative advance breast cancer

13.05-13.25

New heights in the paradigm of HR+ metastatic breast cancer management

13.25-13.30

Discussion

Symposium III

Lung cancer: Enhancing survival outcomes of metastatic patients: from clinical evidence to clinical excellence

13.30-13.50

Lung cancer diagnosis in the precision oncology era: navigating clinical and procedural challenges

13.50-14.15

Targeted treatments in early to advance NSCLC

14.15-14.30

Case sharing and discussion in metastatic lung cancer

14.30-14.50

Discussion

Symposium IV

Colorectal cancer: maximizing tumor control and tackling toxicities in advanced disease

14.50-15.10

Optimizing the continuum of care in metastatic colorectal cancer: current strategies and future directions

15.10-15.30

Case sharing

15.30-15.50

Discussion

15.50-16.05

Booth-side refreshment

Dinner Meeting Session

Triple-Negative Breast Cancer with Brain Metastases: Evolving Treatment Strategies

19.00-19.05

Opening

19.05-19.30

Case presentation

19.30-19.40

Discussion

19.40-19.50

Remarks from ICF

19.50-20.00

Remarks from Perhompedin Jogja

20.00-20.10

Discussion

20.10-20.15

Closing

07.00-07.20

Participant registration

07.20-07.25

Opening

07.25-07.30

Guest lecture opening

07.30-07.50

Understanding triple negative breast cancer heterogenity: from molecular subtyping to precision therapeutics

07.50-08.00

Discussion

Symposium V

Current challenges and surfacing trend in the treatment of ALK-lung cancer

08.00-08.20

Advances and diagnostic challenges in lung cancer pathology

08.20-08.40

Treatment strategies accross lines of treatment for ALK-rearranged NSCLC

08.40-09.05

ALK-Targeted Therapy in Clinical Practice: Learning Through Cases

09.05-09.15

Discussion

Parallel Symposium I

HR+/HER2- Breast Cancer: Advancing Precision Care Across the Patient Journey

09.45-10.05

Advances in breast imaging: optimizing diagnosis, staging, and treatment monitoring in HR+/HER2- breast cancer

10.05-10.25

Breast cancer: Management of HR+/HER2- disease: latest practices, future directions, and unanswered questions

10.25-10.45

Overcoming Endocrine Resistance in HR+/HER2- Breast Cancer: Current Strategies and Future Directions

10.45-10.55

Discussion

Parallel Symposium II

Advancing precision in hematology oncology: from molecular insights to real world practice

09.45-10.05

Multiple myeloma: The state-of-the-art management across disease continuum

10.05-10.25

Anti-CD38 monoclonal antibodies in multiple myeloma: transforming the treatment landscape

10.25-10.30

Discussion

10.30-10.50

Optimizing Tyrosine Kinase Inhibitor therapy in chronic myeloid leukemia

10.50-10.55

Discussion

Parallel Symposium III

Hepatocellular carcinoma: advances in diagnosis and emerging therapeutic strategies

10.55-11.15

Optimizing the diagnosis of hepatocellular carcinoma: current challenges and best practices

11.15-11.35

Cellular therapy in hepatocellular carcinoma: current evidence and future perspectives

11.35-11.45

Discussion

Parallel Symposium IV

Advances in systemic therapy and supportive care: optimizing patient outcomes

10.55-11.15

The Evolving Role of Immunotherapy in Advanced Renal Cell Carcinoma

11.15-11.35

Personalized Antiemetic Approaches: Quality of Life Outcomes in CINV Control

11.35-11.45

Discussion

Workshop I

Breast cancer MDT: Precision treatment through a teamwork

11.45-11.50

Opening

11.50-12.10

Evolving surgical approach in early stage breast cancer

12.10-12.30

HER2+ breast cancer (early stage)

12.30-12.50

HER2+ breast cancer (advanced stage)

12.50-13.10

Optimizing local control in early to advanced breast cancer

13.10-13.30

Case presentation - Early BC and Panel Case Discussion

Workshop II

Colorectal cancer MDT: Improving outcomes with a personalized care

11.45-11.50

Opening

11.50-12.15

Modern approaches to colorectal cancer surgery: From established standards to emerging techniques

12.15-12.40

Understanding Colorectal Cancer Pathology: Diagnostic, Prognostic, and Predictive Biomarkers

12.40-13.05

Radiotherapy in rectal cancer

13.05-13.30

Case presentation and Panel Case Discussion

Special Symposium

Public speaking and leadership in oncology

13.50-14.10

Public speaking and leadership in oncology

14.10-14.15

Discussion

Special Symposium

Doctorpreneur

Moderator: Salsabila Mutia

14.15-14.40

Financial freedom for doctors

14.40-15.05

Becoming medical influencer vs expert provider

15.05-15.20

Discussion

15.20-15.30

Poster and doorprize winner announcement

15.30-15.35

Closing